M
Mamoru Takenaka
Researcher at Kindai University
Publications - 234
Citations - 2932
Mamoru Takenaka is an academic researcher from Kindai University. The author has contributed to research in topics: Medicine & Endoscopic ultrasound. The author has an hindex of 21, co-authored 179 publications receiving 1782 citations. Previous affiliations of Mamoru Takenaka include Osaka University & Kobe University.
Papers
More filters
Journal ArticleDOI
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
Masatoshi Kudo,Kazuomi Ueshima,S.L. Chan,Tomohiro Minami,Hirokazu Chishina,Tomoko Aoki,Masahiro Takita,Satoru Hagiwara,Yasunori Minami,Hiroshi Ida,Mamoru Takenaka,Toshiharu Sakurai,Tomohiro Watanabe,Masahiro Morita,Chikara Ogawa,Yoshiyuki Wada,Masafumi Ikeda,Hiroshi Ishii,Namiki Izumi,Naoshi Nishida +19 more
TL;DR: In patients with large or multinodular intermediate-stage HCC exceeding the up-to-seven criteria with Child–Pugh A liver function, lenvatinib provides a more favorable outcome than TACE.
Journal ArticleDOI
Computer-Aided Diagnosis Based on Convolutional Neural Network System for Colorectal Polyp Classification: Preliminary Experience.
Yoriaki Komeda,Hisashi Handa,Tomohiro Watanabe,Takanobu Nomura,Misaki Kitahashi,Toshiharu Sakurai,Ayana Okamoto,Tomohiro Minami,Masashi Kono,Tadaaki Arizumi,Mamoru Takenaka,Satoru Hagiwara,Shigenaga Matsui,Naoshi Nishida,Hiroshi Kashida,Masatoshi Kudo +15 more
TL;DR: A CNN-CAD system using routine colonoscopy might be useful for the rapid diagnosis of colorectal polyp classification.
Journal ArticleDOI
Multicenter study of early pancreatic cancer in Japan
Atsushi Kanno,Atsushi Masamune,Keiji Hanada,Hiroyuki Maguchi,Yasuhiro Shimizu,Toshiharu Ueki,Osamu Hasebe,Takao Ohtsuka,Masafumi Nakamura,Mamoru Takenaka,Masayuki Kitano,Masataka Kikuyama,Toshifumi Gabata,Koji Yoshida,Tamito Sasaki,Masahiro Serikawa,Toru Furukawa,Akio Yanagisawa,Tooru Shimosegawa +18 more
TL;DR: This multicenter study revealed several key points concerning the diagnosis and management of early-stage PDAC, including screening of asymptomatic cases, importance of indirect imaging findings, application of cytology during endoscopic retrograde cholangiopancreatography, and the risk of carcinogenesis in the remnant pancreas.
Journal ArticleDOI
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer.
Hisato Kawakami,Junko Tanizaki,Kaoru Tanaka,Koji Haratani,Hidetoshi Hayashi,Masayuki Takeda,Ken Kamata,Mamoru Takenaka,Masatomo Kimura,Takaaki Chikugo,Takao Sato,Masatoshi Kudo,Akihiko Ito,Kazuhiko Nakagawa +13 more
TL;DR: Nivolumab-related cholangitis is associated with distinct imaging and clinicopathological features that distinguish it from acute cholANGitis of common etiologies and other immune-relatedCholangitas.
Journal ArticleDOI
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
Kazuomi Ueshima,Naoshi Nishida,Satoru Hagiwara,Tomoko Aoki,Tomohiro Minami,Hirokazu Chishina,Masahiro Takita,Yasunori Minami,Hiroshi Ida,Mamoru Takenaka,Toshiharu Sakurai,Tomohiro Watanabe,Masahiro Morita,Chikara Ogawa,Atsushi Hiraoka,Philip J. Johnson,Masatoshi Kudo +16 more
TL;DR: Patients with Child–Pugh score of 5 and ALBI grade 1 predicted a higher response rate and lower treatment discontinuation due to adverse events by lenvatinib treatment.